Cutler Group LP Mesoblast LTD Call Options Transaction History

Cutler Group LP

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2023 Nov 07, 2023	BUY	$1.22 - $4.83 $2,196 - $8,694	1,800 New	1,800 $0
Q1 2022 Apr 14, 2022	SELL	$3.58 - $4.98 $11,098 - $15,438	-3,100 Reduced 96.88%	100 $0
Q3 2021 Oct 26, 2021	BUY	$5.87 - $7.85 $11,740 - $15,700	2,000 Added 166.67%	3,200 $0
Q2 2021 Jul 19, 2021	SELL	$6.69 - $9.0 $2,007 - $2,700	-300 Reduced 20.0%	1,200 $0
Q1 2021 Apr 26, 2021	SELL	$8.26 - $11.4 $80,122 - $110,580	-9,700 Reduced 86.61%	1,500 $0
Q4 2020 Jan 21, 2021	BUY	$8.21 - $18.59 $89,489 - $202,631	10,900 Added 3633.33%	11,200 $4,000
Q3 2020 Oct 27, 2020	SELL	$11.33 - $19.81 $1,133 - $1,980	-100 Reduced 25.0%	300 $1,000
Q2 2020 Jul 22, 2020	BUY	$4.2 - $15.45 $1,680 - $6,180	400 New	400 $1,000

151K

Ticker MESO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 147,316,000
Market Cap $2.51B
Description
Mesoblast Limited, a biopharmaceutical company, develops and commercializes allogeneic cellular medicines in the United States, Australia, Singapore, the United Kingdom, and Switzerland. The company offers products in the areas of cardiovascular, spine orthopedic disorder, oncology, hematology, and immune-mediated and inflammatory diseases. Its ...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.